Загрузка...
Light activated, In situ Forming Gel for Sustained Suprachoroidal Delivery of Bevacizumab
PURPOSE: To develop a light activated polycaprolactone dimethacrylate and hydroxyethyl methacrylate based gel network that sustains the release of stable, active bevacizumab (an anti-VEGF antibody used to treat choroidal neovascularization) and to assess sustained ex vivo delivery in rabbit eyes and...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4003910/ https://ncbi.nlm.nih.gov/pubmed/23734705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp300716t |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|